Quantitative proteomics suggests decrease in the secretogranin-1 cerebrospinal fluid levels during the disease course of multiple sclerosis

A.C. Kroksveen, J.D. Jaffe, E. Aasebo, H. Barsnes, Y. Bjorlykke, D. Franciotta, H. Keshishian, K.M. Myhr, J.A. Opsahl, V. van Pesch, C.E. Teunissen, O. Torkildsen, R.J. Ulvik, H. Vethe, S.A. Carr, F.S. Berven

Research output: Contribution to journalArticleAcademicpeer-review

32 Citations (Scopus)
Original languageEnglish
Pages (from-to)3361-3369
Issue number19
Publication statusPublished - 2015

Cite this